![]() | |
Company type | Private |
---|---|
Industry | Private Equity |
Founded | 1989 |
Products | Private equity funds, Buyouts |
AUM | $40 billion (2024) |
Website | nordiccapital |
Nordic Capital is a global private equity firm focused on leveraged buyouts of established companies in Northern Europe and North America.
Founded in 1989, the firm manages about $40 billion of capital, with offices in New York, London, Stockholm, Frankfurt, Copenhagen, Helsinki, and Oslo.
Nordic Capital targets buyouts of large and medium-sized companies across 4 core industries: Technology & Payments, Healthcare, Financial Services, and Services & Industrial Technology. [1]
Nordic Capital is one of the 25 largest private equity firms worldwide according to Private Equity International's PEI 300 ranking, with over $30 billion of capital raised within a 5-year period. [2]
In October 2022, Nordic Capital announced the successful closing of its 11th large-cap buyout fund at its hard cap of EUR 9 billion (USD $10 billion), exceeding its €8 billion target. The fund is over 45% larger than its predecessor large-cap fund (Nordic Capital Fund X), which raised €6.1 billion in 2020. [3] The fund closed in only nine months amidst some of the most challenging fundraising conditions in private equity history, and was the largest Europe-based private equity fund raised that year. [4]
In June 2024, Nordic Capital ranked 38th in Private Equity International's PEI 300 ranking among the world's largest private equity firms. [5]
In February 2025, Nordic Capital won two awards at the Private Equity Wire Europe Awards 2025. [6]
In July 2024, Nordic Capital acquired a majority stake in Sensio, a leading medical technology provider. [7]
In November 2024, Nordic Capital acquired US-based IP management software company Anaqua for approximately $3 billion. The acquisition is expected to close by the first quarter of 2025, subject to approval from the relevant regulatory and antitrust authorities. [8] In the same month, Nordic Capital acquired a controlling stake in Max Matthiessen for over $1 billion. [9]
In October 2024, Nordic Capital was reportedly exploring a potential sale or IPO of fintech company Trustly that could value the portfolio company at over $10 billion. [10] Nordic Capital acquired Trustly in 2018 at a $800 million valuation. [11] In 2024, it was reported that Trustly is on track towards processing $100 billion in Total Payments Value for the year, representing a 33% year-over-year growth. [12]
In August 2024, Hargreaves Lansdown (LON: HL) agreed to be taken private for $7 billion by Nordic Capital and CVC Capital Partners. [13] In the same month, Nordic Capital was said to be exploring a potential IPO of financial services company NOBA that could value the company at over $4 billion. [14]
In June 2024, it was reported that Clario, a US-based healthcare software company owned by Nordic Capital, confidentially filed for an IPO, targeting a valuation of more than $10 billion. [15]
In April 2024, Nordic Capital invested in One Inc, an US-based digital payments platform. [16]
In February 2024, Nordic Capital acquired US-based financial software company ActiveViam. [17]
In January 2024, Nordic Capital acquired Surgical Information Systems, a US-based healthcare software company. [18]
In December 2023, Nordic Capital acquired IntegriChain, a US-based healthcare technology company. [19]
In July 2023, Nordic Capital sold software company Macrobond to Francisco Partners, yielding over 6x multiple of invested capital after first backing Macrobond in 2018. [20] During Nordic Capital's ownership, Macrobond saw its annual contract value (ACV) more than triple, resulting in a remarkable 34% year-on-year growth. In March 2024, Nordic Capital was honored with the Exit of the Year Award at the Private Equity International Awards for the sale of Macrobond. [21]
In January 2023, Nordic Capital completed the sale of The Binding Site to Thermo Fisher Scientific for $2.8 billion. [22] This exit represented a 19x net multiple of invested capital for Nordic Capital. [23]
In October 2022, Nordic Capital invested in medical device company Equashield through a deal valued at over $1.3 billion. [24]
In November 2021, Nordic Capital completed the take-private of US-based healthcare software company Inovalon (NASDAQ: INOV) for $7.3 billion. [25] In accordance with the terms of the agreement, Inovalon stockholders received $41.00 in cash for each share of Inovalon Class A Common Stock and Class B Common Stock. [26]